Temozolomide and radiotherapy in newly diagnosed glioblastoma patients: O6-methylguanine-DNA methyltransferase (MGMT) promotor methylation status and Ki-67 as biomarkers for survival and response to treatment

✍ Scribed by Khaled Abdel Karim; M. M. El Mahdy; M. M. Abdel Wahab; L. R. Ezz EI Arab; A. El Shehaby; S. Abdel Raouf

• Book ID: 113059043
• Publisher: Springer
• Year: 2012
• Tongue: English
• Weight: 464 KB
• Volume: 11
• Category: Article
• ISSN: 1610-1979
• DOI: 10.1007/s10330-011-0928-y